PGIM India Mutual Fund buys stake in Kolte-Patil Developers
In another transaction, Kuber India Fund sold 113,468 shares of Windlas Biotech at Rs. 379.7 apiece through a bulk deal on the NSE.
via Economictimes
via Economictimes
Subscribe to:
Post Comments
(
Atom
)
Post a Comment